Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. - Wikidata - awgldk - TriplyDB

Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist.

Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist.

http://www.wikidata.org/entity/Q46203504

about

Molecular functions of thyroid hormones and their clinical significance in liver-related diseases Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD Thyroid Hormone Mimetics: the Past, Current Status and Future Challenges Endocrine causes of nonalcoholic fatty liver disease New avenues for regulation of lipid metabolism by thyroid hormones and analogs Cross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatment Low-normal thyroid function and novel cardiometabolic biomarkers Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling The amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob mice Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet.Thyroid hormone regulation of metabolism Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner.Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver.Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies Thyroid hormone analogues and derivatives: Actions in fatty liver Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats.Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats.Chinese medicine formula lingguizhugan decoction improves Beta-oxidation and metabolism of Fatty Acid in high-fat-diet-induced rat model of Fatty liver disease.Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone Thyroid hormone-related regulation of gene expression in human fatty liver.Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.Prevalence of hypothyroidism in nonalcoholic fatty liver disease.Fatty acid metabolism and thyroid hormones.Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders.Pharmacological agents for nonalcoholic steatohepatitis.Review article: new treatments in non-alcoholic fatty liver disease.Chemistry and Biology in the Biosynthesis and Action of Thyroid Hormones.Mitochondrial Actions of Thyroid Hormone.Action of Thyroid Hormones, T3 and T2, on Hepatic Fatty Acids: Differences in Metabolic Effects and Molecular Mechanisms.Responses of skeletal muscle lipid metabolism in rat gastrocnemius to hypothyroidism and iodothyronine administration: a putative role for FAT/CD36.Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1.Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia.Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration.Both 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet.Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter.

P2860

Q21284820-51800E89-8A1A-439B-BBCE-0544D4ED4A17 Q26738872-4DDA464A-84A8-444E-9FFF-E4DD9A9F4C16 Q26765178-1383D9D3-A020-4193-AE19-19DE388BFA0C Q26780254-4F49B50D-380C-4044-B850-771500F84C0C Q27003043-58C0CD38-3C29-4CC4-B5CE-4E70475A9599 Q27011338-4C424EBB-119F-4F08-9698-1927C203C009 Q28084990-0A9EB687-7F6E-4577-809B-2246C97DD124 Q28118597-D88691E2-88A4-4956-851C-A5092F9A3330 Q28545792-D8750D61-DA11-4F6D-B4D9-682A3A7A5C12 Q33699311-FAF901C9-123E-4145-B38A-5116E3933F44 Q33700432-46970AA7-8B5B-487C-A3D7-A56C459A5AEE Q33707954-8028D285-7178-4632-AAE2-D8BB6C868462 Q33825136-C71FDDC0-D0E6-490F-90DD-9E78D3D0004A Q33845489-E8D405BF-A9E5-4B3D-9491-7B3097FB017B Q34012181-A6DB255C-B490-4E3C-B5AF-E987401966AB Q34540703-07B21841-609F-4AFD-BE73-F3665A7A596F Q34657286-937A05DF-1655-46E4-95D7-20C61F884D45 Q35132642-CC8784C9-3B43-4AD1-A45D-7AF45D669C9C Q35405379-1A0C8EE9-2A7E-4805-B08C-65BB0D7621F6 Q36819364-9D3C377D-3F72-4937-8D5A-A999758FAABE Q36879157-2F083697-DE52-4725-89AE-1350E71D2770 Q36910027-5D72505A-B50E-45F3-B5B5-DF6308FFED01 Q37341839-45DAD35B-EB3C-4183-A494-A2C213D365D0 Q37457241-29D79509-092F-4D8E-A466-077CD66EB48E Q37460346-ECA4E494-0C3B-4000-A71B-3E0BEF2233EE Q37579996-537802A8-63F8-404C-8A15-74C1FC7DC34F Q38179362-71F6E8E2-FBFA-47F7-95FF-FF650CCD67CE Q38359090-C14B88B7-82C7-412F-9BE6-01D6C0BFDBE2 Q38552387-7CEF2F40-2294-4022-8764-728DBF28BEBF Q38662765-AE7AE26D-251B-4C4B-8EC1-E3A4D1735179 Q38844606-239117A5-720A-45B9-BA9B-4D91CFD96BB3 Q38991456-22915F69-D294-4588-9AB6-C2F8F814239F Q39210935-97D12560-015F-4E09-B008-FA70C0F0A7A3 Q39281132-71B60F70-8203-4CE5-98CF-C5CF9E45CA35 Q39446395-54BDAC19-0EAA-44C7-975D-7C76DEB690C0 Q39557699-29B079D4-C0EA-4068-AAE6-54E30C03E6FA Q40069909-2108E5D7-EBDB-4044-941A-DA684B567491 Q40813387-51A15FF5-2E9A-4488-852E-3493CC95DFEE Q41673359-C19038CF-E636-4826-8557-FA5EAE690B93 Q44518982-EA85D48E-5414-44CB-A8EC-8B4DA732CF86

P2860

Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist.

http://www.wikidata.org/entity/Q46203504

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Reduction of hepatic steatosis ...... roid hormone receptor agonist.

@en

Reduction of hepatic steatosis ...... roid hormone receptor agonist.

@nl

type

label

Reduction of hepatic steatosis ...... roid hormone receptor agonist.

@en

Reduction of hepatic steatosis ...... roid hormone receptor agonist.

@nl

prefLabel

Reduction of hepatic steatosis ...... roid hormone receptor agonist.

@en

Reduction of hepatic steatosis ...... roid hormone receptor agonist.

@nl

P1433

Q46203504-E450D4B5-CEB9-4123-8F72-5A3F4A9123F4

P1476

Q46203504-62CA06DE-9BD0-4A93-A788-9B94BD7B3DC6

P2093

Q46203504-1D2E56D0-EE26-4370-AAA8-3C3C6151791B

Q46203504-6C72D771-E389-4A5C-94DC-FB20E5669DE3

Q46203504-AD33F5D8-9C03-4D05-946C-7343D4618513

Q46203504-BE2F45D9-AB12-4AC6-9174-7101564E3984

Q46203504-C9077A29-397E-4741-A45B-A5158CD6D91D

Q46203504-D4370207-0810-400D-8D12-1267BD2A886B

Q46203504-DB46E05B-1735-4920-978E-3DCBDE320841

Q46203504-E53B9712-4839-49DA-B367-12269A8AA187

P2860

Q46203504-03F9058B-5745-4F07-9D61-651A61BB1663

Q46203504-18F1BF85-AAE6-4A2A-B824-3E91E7739F21

Q46203504-34E33E6B-9672-4CA6-9171-BE7DACCE0000

Q46203504-3E865AF4-92B1-452F-B3DE-5B5C9CF65A44

Q46203504-4DD2F9A1-375F-49C2-8C60-EB34B1325720

Q46203504-4E1F5DE8-7ECB-4884-9680-BD3F3F5C913A

Q46203504-4E28AEEC-17F1-4BD3-AE98-64B026406C28

Q46203504-5BDA7CB0-06DE-49C5-B8DE-39C371825100

Q46203504-62089ADE-AB38-4A47-A632-E7D35A2289FE

Q46203504-6BD785CF-883D-431A-8D5B-A5C18D7AD7D1

P304

Q46203504-A3CFB59B-D7FA-4A02-B920-8BCE5452D9E4

P31

Q46203504-A913A975-2E9C-42D0-B004-A8D0A609F199

P356

Q46203504-ECC3200B-ADB0-4E16-8595-C8C35207BC28

P407

Q46203504-4DB60EEE-E8B8-4149-8D59-40D96F0F848D

P433

Q46203504-80C5ED43-0C74-4115-A0DC-9C1AD6E9A18A

P478

Q46203504-51D308FC-3D7C-4243-AD90-8249B6B66E0B

P577

Q46203504-23A74D62-0892-47B9-A6B1-7CBDE74BAE7A

P5875

Q46203504-89CA9A3B-F2B9-4F02-B9F1-0610F7EA316A

P698

Q46203504-5F98D12C-D731-438A-A0D0-07A2ABAFE6B2

P356

P1433

P1476

Reduction of hepatic steatosis ...... roid hormone receptor agonist.

@en

P2093

Bruce R Ito

http://www.w3.org/2001/XMLSchema#string

David L Linemeyer

http://www.w3.org/2001/XMLSchema#string

Edward E Cable

http://www.w3.org/2001/XMLSchema#string

Jeffrey W Stebbins

http://www.w3.org/2001/XMLSchema#string

Jinzhao Hou

http://www.w3.org/2001/XMLSchema#string

Mark D Erion

http://www.w3.org/2001/XMLSchema#string

Patricia D Finn

http://www.w3.org/2001/XMLSchema#string

Paul D van Poelje

http://www.w3.org/2001/XMLSchema#string

P2860

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone

Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index

Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice

Cholesterol biosynthesis and metabolism

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice

Thyroid hormones and their effects: a new perspective.

Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability.

P304

407-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22572

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23653739

http://www.w3.org/2001/XMLSchema#string

P698

19072834

http://www.w3.org/2001/XMLSchema#string